Life Sciences
A strong MFN law could be a meaningful step toward bringing U.S. prices in line with those paid by other high-income countries, says Patients for Affordable Drugs Now.
Physicians tell Dr. Amy Bucher they feel a sense of empowerment in being able to offer patients something that, along with lifestyle changes, reduces weight, lowers the risk of diabetes and high blood pressure, and helps prevent other chronic conditions.
For his upcoming HIMSS26 presentation, ChristianaCare's Greg O'Neill discusses how practical tools like plain language, pictograms, multilingual translation and tailored discharge instructions can boost medication compliance.
Amazon is competing with Walmart in the delivery business and against pharmacies such as CVS and Walgreens.
Emerging Technologies
Dr. Amit Zabtani, an orthopedic surgeon at UCLA and cofounder and CMO of CustoMED, says the company uses 3D printing to create patient-specific instruments based on an individual’s anatomy, enabling more precise positioning during surgery.
The company will use the funds to advance its brain shuttle platform that delivers RNAi therapies across the blood-brain barrier to help treat neurodegenerative diseases.
The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.
Patients can see the discounted prices on TrumpRx.gov, but the site does not currently sell the drugs.
Emerging Technologies
Sergio Calvo, general manager of theranostics at GE HealthCare, discusses the organization's use of theranostics in cancer care and how the technology combines targeted therapy with diagnostic imaging for personalized oncology care.
Despite tightening barriers to entry over the years, Europe and the US are still key to global expansion for Korean startups, says Sky Labs CEO Jack Byunghwan Lee.